N ormal cardiac function is controlled by the proper coordination of electric conduction and mechanical contractility. 1 Under pathological conditions, the heart undergoes remodeling resulting from changes in structural and electric properties. 2, 3 A hallmark of electric changes in impulse conduction is a change in electric coupling because of abnormal expression of Cx43 (connexin 43), the most abundant cardiac gap junction protein. In the adaptive or compensatory cardiac hypertrophic stage, Cx43 expression is increased and often associated with lateralization, whereas in dilated cardiomyopathy (DCM) or in the decompensatory stage, Cx43 expression is decreased and associated with heterologous distribution in the ventricle. [4] [5] [6] [7] Consistently, animals with cardiac-specific ablation of Cx43 exhibit slowed conduction and spontaneous ventricular arrhythmia. 8 
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The expression of Cx43 is regulated transcriptionally by transcription factors and the different use of promoter regions or translationally by microRNA. [9] [10] [11] [12] [13] In addition, Cx43 protein has a rapid turnover rate, with a half-life of ≈1.5 hours in primary cultures of rat neonatal myocytes and the adult rat heart. highly expressed in the embryonic heart and downregulated in the adult heart. This temporal expression pattern during heart development is regulated by PKC (protein kinase C)-mediated hyperphosphorylation resulting in increased CELF1 steady-state levels. 17 Elevated CELF1 expression in the adult heart has been implicated in the cardiac pathogenesis of myotonic dystrophy type 1 (DM1). 18 DM1 is caused by the expansion of CTG repeats in the 3ʹ untranslated region (UTR) of DMPK (DM protein kinase) gene. Nuclear accumulation of DMPK mRNA containing expanded CUG repeats affects nuclear and cytoplasmic activities of RNA-binding protein families such as MBNL (muscleblindlike) and CELF. 19 The heart manifestations of DM1 include conduction defects, DCM, ischemia, and heart failure. 20 , 21 Although reexpression of CELF1 in the adult mouse heart recapitulates cardiac phenotypes in DM1, such as conduction defects and DCM, 22 how elevated CELF1 expression causes cardiac phenotypes still remains elusive. Whether elevated CELF1 level is a unique feature of the DM1 heart or a shared feature of other cardiovascular diseases has not been determined.
In the present study, we showed increased CELF1 expression in a mouse model of myocardial infarction (MI) by ligating the left anterior descending (LAD) artery, a model also exhibiting DCM. Genes regulated by CELF1, including Cx43, are important in controlling cardiac contractility and conduction. The 3ʹUTR of Cx43 contains several CELF1-recognized UG-rich motifs. CELF1 bound to the UG-rich elements and downregulated Cx43 mRNA by interacting with a 3ʹ to 5ʹ exoribonuclease, RRP6 (ribosomal RNA processing protein 6), the nuclear component of exosome complex. 23 Both nuclear localization of CELF1 and function of RRP6 were required for CELF1-mediated Cx43 mRNA degradation. CELF1 and RRP6 protein levels were found upregulated along with downregulated Cx43 in mouse models of DCM, including DM1, CELF1 overexpression (CELF1-OE), and MI. 24 Importantly, CELF1 depletion in the infarcted heart preserved Cx43 mRNA level and ameliorated contractile dysfunction. Our results provide a mechanism for CELF1-mediated Cx43 mRNA degradation and suggest a pathogenic role of CELF1 in DCM.
Methods
Expanded Methods and Materials are available in the Online Data Supplement.
RNA Immunoprecipitation
To determine CELF1 and Cx43 mRNA interaction in HL-1 cells and in mouse hearts, the Magna RNA Immunoprecipitation RNA-Binding Protein Immunoprecipitation Kit (Millipore) was used according to 
Novelty and Significance
What Is Known?
• Cx43 (connexin 43) is the major cardiac gap junction protein that modulates electric coupling, and its reduction is often associated with dilated cardiomyopathy (DCM), the most common cause of heart failure.
• CELF1 (CUGBP Elav-like family member 1) is an RNA-binding protein that regulates alternative splicing and mRNA degradation, and its increased expression is implicated in the cardiac pathogenesis of myotonic dystrophy type 1.
• How elevated CELF1 expression causes DCM and heart failure remains largely elusive.
What New Information Does This Article Contribute?
• CELF1 regulates Cx43 mRNA degradation by interacting with a nuclearspecific exoribonuclease RRP6 (ribosomal RNA processing protein 6).
• CELF1 elevation associated RRP6 upregulation and Cx43 reduction is commonly seen in mouse models exhibiting DCM including DCM induced by acute myocardial infarction.
• Depletion of CELF1 in a heart-specific Celf1-knockout model preserves Cx43 expression and ameliorates the cardiac dysfunction of the acute infarcted heart.
Under pathological conditions, reduced Cx43 expression is a hallmark of the transition from adaptive or compensatory stage to decompensation and heart failure. The regulatory mechanism controls the transition leading to reduced Cx43 expression is largely unknown, in particular, the regulation at the post-transcriptional level. In this study, we provided a new mechanistic insight into the pathogenesis of Cx43 reduction in DCM, the most common cause of heart failure. We showed that CELF1 mediated Cx43 mRNA degradation by binding to Cx43 and interacting with an exoribonuclease RRP6 in an RNA-independent and nucleusspecific manner. Increased CELF1 expression accompanied with RRP6 upregulation and downregulation of CELF1-mediated target genes including Cx43 was detected in 3 mouse models of DCM: myotonic dystrophy type 1, CELF1 overexpression, and myocardial infarction. Importantly, using a heart-specific Celf1-knockout mouse model, we showed that Celf1 depletion in infarcted heart ameliorated the contractility dysfunction and preserved Cx43 mRNA level.
The results not only demonstrate a pathogenic role for CELF1 in contributing to the Cx43 mRNA degradation during heart failure but also suggest that increased CELF1 expression may be a common feature of DCM and CELF1 might be a potential therapeutic target in both acute and chronic heart failure. October 27, 2017 the manufacturer's instructions. In brief, cells were harvested after reaching confluence, and mouse hearts were freshly dissected and then underwent RNA immunoprecipitation. Monoclonal anti-CELF1 antibody (Millipore) was used for immunoprecipitation. The information on primer sequences for amplification of CELF1 target genes is given in Online Table III .
Generation of Celf1-Knockout Mouse Model
The Celf1 gene was knocked out by deletion of exon 3, which results in a reading frame shift mutation. To generate a conditional deletion of Celf1, the targeting vector was generated by a recombineeringbased method. 25 The mouse Celf1 genomic DNA was obtained from bacterial artificial chromosome clone bMQ-325j03 (source BioScience Geneservice Ltd). The targeting construct was generated to replace exon 3 of Celf1 gene with 2 copies of loxP sites flanking exon 3 of Celf1 with 2 selections: neomycin cassette flanked with 2 FRT sites and thymidine kinase via homologous recombination. The targeted embryonic stem cells were selected by using a neomycin cassette and thymidine kinase followed by Southern blot analysis. The targeted embryonic stem cells were injected into blastocysts of B6 mice to generate chimeric male mice. Construction of targeting vector, screening of embryonic stem cells, and chimera production were performed by the transgenic mouse model core facility of National Taiwan University. The chimeric mice were bred with B6 female mice, and the offspring with an agouti coat color were genotyped by using Southern blot analysis to confirm germline transmission. Mice carrying floxed Celf1 (Celf1 floxed/+ or Celf1 F+ ) were backcrossed into the B6 background. All animal experiments were performed with the approval of the Academia Sinica Institutional Animal Care and Utilization Committee in strict accordance with its guidelines and those of the Council of Agriculture Guidebook for the Care and Use of Laboratory Animals.
Statistical Analysis
Results are presented as mean±SEM. P values were determined by Student t test for 2 groups and 1-way ANOVA followed by Tukey test for multiple groups. P <0.05 was considered statistically significant.
Results

Genes Involved in Cardiac Function Are Downregulated in the CELF1-Overexpressing Heart
Induced CELF1 expression in adult cardiomyocytes causes arrhythmia, DCM, and heart failure. 18, 22 To investigate how increased CELF1 expression contributes to cardiac phenotypes, we determined gene expression profiles in the CELF1-OE heart by microarray assay and identified 1153 genes upregulated and 453 downregulated with at least 1.5-fold change (Online Table IA ). We further characterized downregulated genes because CELF1 has been suggested to regulate mRNA stability. 26, 27 Ingenuity Pathway Analysis used to classify the differentially expressed genes showed downregulation of 14 genes functionally associated with DCM (Tfam, Apln, Acsl1; P=4E-02), contraction (Srl, Atp2a2, Rgs2, Ryr2, Atp1b1, Slc8a1, Tnnt2; P=8.74E-05), or conduction (Tbx5, Rgs6, Asph, Cx43; P=1.02E-02) in CELF1-OE mouse hearts ( Figure 1A ; Online Table IB) .
The 3ʹUTR of these 14 genes contained at least 2 copies of UG-rich elements known to be CELF1 recognition motifs and regulators of mRNA stability 26 (Online Table II ). To confirm that these were CELF1-regulated targets, [28] [29] [30] we performed RNA immunoprecipitation assay with anti-CELF1 antibody and cell lysates from the cardiomyocyte cell line HL-1. Except for Rgs2, all 13 genes were immunoprecipitated by anti-CELF1 antibody ( Figure 1B) , which suggests that they are CELF1 target genes. Rgs2 was not immunoprecipitated because of lack of expression in HL-1 cells originally derived from the atrium but was expressed in the mouse heart ventricle ( Figure 1B) . Consistently, CELF1-bound targets were confirmed in CELF1-OE hearts ( Figure 1C ). Thus, CELF1 downregulated genes involved in cardiac contraction and conduction.
Downregulation of Cx43 in Cells Overexpressing CELF1
We previously showed significantly reduced Cx43 protein level in a mouse model of DM1 (EpA960/MerCreMer [MCM]) with expanded CUG RNA induced in cardiomyocytes. 18 PKC inhibition and reduced hyperphosphorylated CELF1 level partially preserved Cx43 expression and ameliorated the cardiac phenotypes of mice with DM1. 31 Cx43 mRNA level was reduced in CELF1-OE hearts ( Figure 1A ) and EpA960/MCM (DM1) hearts ( Figure 2A ). Because CELF1-OE and EpA960/ MCM animals exhibited similar cardiac phenotypes, including conduction defect, DCM, and heart failure, and the Cx43 3ʹUTR contains several CELF1 recognition UG-rich motifs, we wondered whether CELF1 regulates Cx43 mRNA expression. We first examined the distribution of Cx43 in EpA960/ MCM and CELF1-OE hearts. In control MCM hearts, Cx43 was mainly localized in the intercalated disc region ( Figure 2B ), but its expression was reduced in EpA960/MCM hearts. Similarly, Cx43 was barely detected in cardiomyocytes in the intercalated disc region with induced expression of CELF1 but was well detected in the intercalated disc region in the noninduced heart ( Figure 2C ).
Next, we cotransfected CELF1 and human Cx43 cDNA containing its 3ʹUTR in HEK293 cells and found that CELF1 dose dependently downregulated Cx43 protein and mRNA levels ( Figure 2D ). Overexpression of CELF1 downregulating Cx43 level was also seen in HL-1 cells (Online Figure  I ). Use of a CELF1-specific shRNA to deplete endogenous CELF1 increased both mRNA and protein levels of Cx43 in HL-1 cells ( Figure 2E and 2F), which suggests that CELF1 regulates Cx43 expression.
CELF1 Regulates Cx43 mRNA Stability
To investigate how CELF1 regulates Cx43 mRNA expression, we first determined whether CELF1 regulates Cx43 mRNA stability. We measured the mRNA half-life of endogenous Cx43 in HL-1 cells by inhibiting transcription with actinomycin D. At different times after actinomycin D treatment, CELF1 mRNA level did not change (Online Figure IIA) . The half-life of Cx43 mRNA was ≈67 minutes ( Figure 3A) ; knockdown of CELF1 with lentivirus delivery of an shRNA for endogenous CELF1 extended the half-life to ≈121 minutes ( Figure 3A ; Online Figure IIB ), which suggests that CELF1 regulates Cx43 mRNA stability. We next determined whether the elements regulating Cx43 mRNA stability by CELF1 were localized in the 3ʹUTR. A luciferase reporter construct carrying Cx43 3ʹUTR (Luc-Cx43 3ʹUTR) was cotransfected with CELF1 in HEK293 cells. Overexpression of CELF1 shortened the half-life of Cx43 mRNA ( Figure 3B ), so the regulatory elements in the Cx43 3ʹUTR may contribute to regulating its mRNA stability.
The Cx43 3ʹUTR (nucleotides 841-852) contains a consensus CELF1 recognition UG-rich element (GRE), 26 UGUUUUGUUUGU ( Figure 3C ). We determined whether CELF1 bound to the region (Cx43 3ʹUTR-2ND, nucleotides 522-1061) containing this GRE by electrophoretic mobility shift assay. Recombinant GST-CELF1 protein but not GST protein bound to the radioactive labeled Cx43 3ʹUTR-2ND RNA, as indicated by the band shift ( Figure 3D , lane 3, arrowhead). Competition of the binding with excess unlabeled Cx43 3ʹUTR-2ND RNA abolished the binding of GST-CELF1 protein to radiolabeled Cx43 3ʹUTR-2ND RNA ( Figure 3D , lane 4), whereas the addition of anti-CELF1 antibody resulted in a supershift indicating the interaction with the CELF1-RNA complex ( Figure 3D , lane 5). We further determined whether the GRE was involved in the binding specificity. The addition of excess unlabeled GRE significantly reduced the binding of recombinant GST-CELF1 protein to radiolabeled RNA (Cx43 3ʹUTR-2ND, nucleotides 772-921; Figure 3E ). Removal of the region containing GRE (Cx43 3ʹUTR-2ND, nucleotides 772-921 ΔGRE ) abolished GST-CELF1 protein binding to radiolabeled RNA ( Figure 3F ), so GRE in the Cx43 3ʹUTR may be required for CELF1 binding. In addition, we cotransfected Flag-CELF1 with the mutant construct that did not contain GRE in the Cx43 3ʹUTR (Luc-Cx43 3ʹUTR-2ND
522-1061ΔGRE
) into HL-1 cells; CELF1 did not downregulate the reporter mRNA expression ( Figure 3G ). Thus, CELF1 may regulate Cx43 mRNA stability by recognizing GRE residing in the Cx43 3ʹUTR.
RRP6 Interacts With CELF1
To further determine how CELF1 regulates Cx43 mRNA degradation, we performed immunoprecipitation followed by LC-MS/MS to identify CELF1-interacting proteins. We previously showed elevated CELF1 expression in the nuclei of cells expressing expanded CUG RNA, 18 so we used nuclear extracts from HEK293 cells overexpressing Flag-CELF1 for immunoprecipitation. RRP6 or exosome component 10, the nuclear component of exosome complex with 3ʹ to 5ʹ exonuclease activity, 23 was identified as the candidate CELF1-interacting protein. We first determined whether CELF1 interacted with RRP6 by using nuclear and cytoplasmic fractions from HEK293 cells expressing Flag-CELF1 for immunoprecipitation. Endogenous RRP6 was distributed in both the cytoplasm and nucleus of HEK293 cells ( Figure 4A ). However, only the nuclear fraction of RRP6 was immunoprecipitated by anti-Flag antibody, which suggests that CELF1 may interact with RRP6 in the nucleus. Similarly, in HL-1 cells, most of the endogenous CELF1 and RRP6 were present in the nucleus, and CELF1 colocalized with RRP6 in the nucleus ( Figure 4B ). Use of anti-CELF1 antibody immunoprecipitated down endogenous RRP6 only from the nuclear fraction ( Figure 4C ). Consistently from the nuclear lysate of the induced but not noninduced CELF1-OE heart, endogenous RRP6 was immunoprecipitated using anti-Flag antibody ( Figure 4D ), which indicated that CELF1 interacted with RRP6 in the nucleus.
We next determined whether the interaction of CELF1 and RRP6 depended on an association with RNA by investigating cell lysates expressing Flag-CELF1 and Myc-RRP6 with or without RNase treatment. The interaction of CELF1 and RRP6 was RNA-independent ( Figure 4E ). We also generated constructs expressing different regions of CELF1 to determine interacting domains. Protein lysates from HEK293 cells expressing the Flag-tagged constructs without RNA recognition motif 1 (RRM1) and RRM2 were not stable (data not shown), so we used GFP-tagged constructs for immunoprecipitation. RRM1 and RRM2 of CELF1 did not interact with Myc-RRP6, whereas regions of CELF1 containing a divergent domain and RRM3 or RRM3 alone interacted with Myc-RRP6 ( Figure 4F ), so RRM3 was required for the interaction. 
RRP6 Is Required for CELF1-Mediated Cx43 mRNA Degradation in the Nucleus
The interaction of CELF1 and RRP6 in the nucleus suggested that CELF1-regulated Cx43 mRNA degradation may occur in the nucleus. To test this, we examined the Cx43 mRNA level in the cytoplasmic and nuclear fractions of cells cotransfected with Cx43 cDNA and Flag-CELF1 or control vector. Compared with the control vector-transfected group, cotransfection with Cx43 cDNA and Flag-CELF1 did not affect the cytoplasmic fraction of Cx43 mRNA ( Figure 5A , lanes 1 and 2) but reduced the nuclear fraction of Cx43 mRNA ( Figure 5A, lanes 4 and 5) . We also examined the effect of CELF1 overexpression on the cytoplasmic and nuclear fractions of Cx43 mRNA level in CELF1-OE mouse hearts. In CELF1-OE hearts, Cx43 mRNA level was reduced in both cytoplasmic and nuclear fractions when compared with the control heart ( Figure 5B ). The reduction was greater in the nuclear than cytoplasmic fraction (74% versus 30%). Thus, CELF1 overexpression caused Cx43 mRNA degradation in the nucleus.
Moreover, we generated a CELF1 mutant construct with mutation of a nuclear localization signal within the RRM3 522-1061ΔGRE and Cx43 3ʹUTR-2ND 772-921ΔGRE represent the deleted GRE. D, EMSA of CELF1 binding to Cx43 3ʹUTR RNA containing GRE. GST-CELF1 or GST recombinant proteins were incubated with radiolabeled RNA generated from Cx43 3ʹUTR-2ND 
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region from arginine to asparagine at residues 471 and 478 (Flag-CELF1 RR471.478DD ). 32 The wild-type Flag-CELF1 mainly localized in the nucleus, whereas Flag-CELF1 RR471.478DD distributed in the cytoplasm ( Figure 5C ). The expression of Flag-CELF1 RR471.478DD did not downregulate Cx43 mRNA in the cytoplasm or nucleus ( Figure 5A, lanes 3 and 6) . The mutant Flag-CELF1 RR471.478DD still bound to the Cx43 mRNA, as shown by RNA immunoprecipitation assay (Online Figure IIIA) , which was consistent with a previous report that recognition and binding of target RNAs is contributed by RRM1 and 2 domains of CELF1. 33 However, the mutations resulted in reduced interaction of Flag-CELF1 RR471.478DD and RRP6 (Online Figure IIIB) . Thus, nuclear localization of CELF1 and its interaction with RRP6 may be required for CELF1 function.
We further studied the involvement of RRP6 in CELF1-mediated Cx43 mRNA degradation. Overexpression of RRP6 alone did not affect Cx43 expression ( Figure 5D ), but coexpression with CELF1 downregulated Cx43 expression, so CELF1 may function as a coactivator of RRP6. To determine whether RRP6 was required for CELF1 function, we used RRP6-specific shRNA to knock down endogenous RRP6. In HL-1 cells with depleted endogenous RRP6, the half-life of Cx43 mRNA was prolonged ( Figure 5E ). On depletion of endogenous RRP6 in HEK293 cells, CELF1 did not downregulate Cx43 mRNA level ( Figure 5F ). Therefore, RRP6 may be required for CELF1 regulating Cx43 mRNA degradation, and their interaction is RNA-independent and nuclear specific.
Upregulation of CELF1 and RRP6 in Mouse Hearts With DCM
We next determined whether the expression of RRP6 was changed along with elevated CELF1 expression in CELF1-OE and EpA960/MCM hearts. RRP6 was highly expressed in the embryonic heart and downregulated in the adult heart, with a similar pattern to CELF1 expression (Online Figure  IVA) . RRP6 was upregulated (Online Figure IVB and IVD) and colocalized with CELF1 in the nucleus of cardiomyocytes (Online Figure IVC and IVE) in CELF1-OE and EpA960/ MCM hearts.
Both CELF1-OE and EpA960/MCM hearts exhibit DCM, so we wondered whether increased CELF1 expression is also a shared feature of DCM. In a previous pressure overload model of hypertrophy by transverse aortic banding, CELF1 expression was not changed 8 weeks after transverse aortic banding. 34 We determined whether CELF1 might be affected in the infarcted heart after LAD ligation, 35 a model also exhibiting DCM. CELF1 expression was induced in left ventricles (LVs) of mouse hearts with MI at 2 and 7 days after LAD ligation when compared with sham control hearts ( Figure 6A ). Increased CELF1 level was detected in cardiomyocytes at the border region near the infarcted site ( Figure 6B ). Cx43 was distributed in intercalated discs of cardiomyocytes in shamoperated mice but downregulated in cardiomyocytes with elevated CELF1 expression ( Figure 6C ). Similarly, RRP6 was upregulated and colocalized with CELF1 in cardiomyocytes at the border region (Online Figure IVF and IVG) . We also found increased phospho-PKC α/βII expression, which suggests that elevated CELF1 expression was likely because of the activation of the PKC pathway. CELF2 level was also increased in EpA960/MCM hearts. 18 Therefore, we examined the expression level of 2 other CELF family members, CELF2 and 4, in MI hearts and found CELF2 level increased, with no change in CELF4 level (Online Figure IVF) .
We further examined the expression of CELF1-regulated targets in EpA960/MCM and MI hearts. Consistent with the downregulation in CELF1-OE hearts, in addition to Cx43 mRNA level, levels of CELF1-regulated mRNAs including Tfam, Atp2a2, Ryr2, Tbx5, and Asph were reduced in EpA960/MCM hearts (Online Figure V) . Similarly, CELF1 
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October 27, 2017 also bound to its target mRNAs ( Figure 6D ) with downregulation of the same mRNAs targets seen in EpA960/MCM hearts ( Figure 6E ). Thus, diseased mouse hearts with DCM commonly showed upregulated CELF1 and RRP6 with downregulation of CELF1-mediated target genes.
Depletion of CELF1 Ameliorated the Cardiac Phenotypes of the Infarcted Heart
To further demonstrate that increased CELF1 expression is pathogenic and also a shared feature of DCM hearts, we generated a heart-specific inducible Celf1-knockout mouse model ) mice with a heart-specific Cre line, MCM, with Cre recombinase expressed in cardiomyocytes on tamoxifen administration. 36 Celf1 knockout in adult cardiomyocytes did not affect the cardiac function of Celf1 FF /MCM animals; mice exhibited normal contractility and cardiac structure (Online Figure VII) . To examine the role of Celf1 FF /MCM in the acute MI heart, we depleted Celf1 expression by tamoxifen administration followed by LAD ligation. Cardiac function was monitored by echocardiography at 1, 2, and 4 weeks after MI ( Figure 7A ). The efficiency of Celf1 knockout was determined by Western blot analysis 4 weeks after MI ( Figure 7B ). Hearts from control animals showed fibrosis near the infarct site in the LV, as revealed by Masson trichrome staining ( Figure 7C ). Compared with the control heart, Celf1 FF /MCM hearts showed a smaller extent of fibrosis ( Figure 7D ) and infarct size ( Figure 7E ). However, at 1 day after LAD ligation, the initial infarct size and area at risk were similar in animals undergoing surgery (Online Figure VIIIA-VIIIC) , which suggests a similar initial response to infarction between control and Celf1 FF /MCM hearts. We next examined the effect of Celf1 depletion on cardiac function in MI hearts. The post-MI LV contractile abnormalities revealed by fractional shortening were less severe in Celf1 FF /MCM than control mice including Celf1 FF and MCM ( Figure 7F ). Although both Celf1 FF /MCM and control mice showed dilated LV internal diameter (LVID) in diastole ( Figure 7G ), Celf1 FF /MCM but not control mice showed nearnormal LVID in end systole, with preserved LV contractility ( Figure 7H ). The near-normal LVID in end systole was maintained in Celf1 FF /MCM hearts up to 4 weeks after MI when compared with control hearts. Celf1 FF /MCM hearts may have better preservation of viable LV muscle tissue with decreased chamber dilatation at end systole, thus maintaining the nearnormal LV contractility post-MI.
We examined Celf1-regulated mRNA levels of target genes including Cx43 and found that the mRNA levels of Tnnt2, Tbx5, and Cx43 in Celf1 FF /MCM mice were restored and comparable to those in sham-operated mice ( Figure 7I) . However, the mRNA levels of Tfam, Atp2a2, Ryr2, and Asph were not recovered in Celf1 FF /MCM mice at 4 weeks after MI. The preserved Cx43 expression was localized in the intercalated disc of cardiomyocytes in Celf1 FF /MCM Figure 7J ). The near-normal LVID in end systole was maintained in Celf1 FF /MCM hearts 1 week after MI, so we wondered whether the Cx43 mRNA level was preserved at early time points. At 1 week post-MI, the Cx43 mRNA level was preserved in Celf1 FF /MCM hearts (Online Figure VIIID) . Thus, depletion of CELF1 in infarcted hearts ameliorated the contractility dysfunction and preserved the mRNA levels of CELF1-regulated target genes such as Tnnt2, Tbx5, and Cx43.
Discussion
Sudden cardiac death because of conduction defect is the major cause of mortality in patients with heart failure.
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Cx43 downregulation is associated with DCM and heart failure, [5] [6] [7] 38 but the underlying mechanism was unclear. Here, we showed upregulated CELF1 only in cardiac tissues featuring dilation and heart failure but not hearts with compensated hypertrophy. 34 We found Cx43 mRNA degradation mediated by CELF1 implicated in the cardiac pathogenesis of DM1. CELF1 recognized the UG-rich motif in the 3ʹUTR of Cx43 and regulated its mRNA stability by interacting with RRP6, a 3ʹ to 5ʹ exoribonuclease, in the nucleus. RRP6 interacted with CELF1 in an RNA-independent manner and was required for CELF1-mediated Cx43 mRNA degradation. Mouse hearts with DCM showed upregulated CELF1 and RRP6 accompanied by downregulation of Cx43 mRNA. Moreover, depletion of CELF1 in infarcted hearts ameliorated the contractility dysfunction and preserved the Cx43 mRNA level. Therefore, our results suggest that increased CELF1 expression may contribute to the pathogenesis of Cx43 downregulation during heart failure.
During cardiac remodeling, the molecular mechanism involved in the transition from compensated hypertrophy to decompensation and heart failure remains elusive. Whether genes are differentially expressed in the adaptive and decompensated stages is still largely unknown. CELF1 is downregulated in the adult heart and upregulated in the DM1 heart, similar to its embryonic pattern. 17 We detected upregulated CELF1 only in cardiac tissues featuring dilation and heart failure but not hearts with compensated hypertrophy. 34 Intriguingly, consistent with the results seen in the CELF1-OE heart, upregulation of CELF1 and RRP6 in DM1 and MI hearts was also associated with downregulation of CELF1 targets including Tfam, Atp2a2 (or Serca2), Ryr2, Tbx5, Asph, and Cx43. Importantly, downregulation of these genes is also seen in patients with DCM or heart failure.
6,39-43 Therefore, our results suggest that upregulated CELF1 may play a role in the transition to decompensation and heart failure.
RRP6 is the nuclear subunit of an exosome ribonuclease complex involved in RNA processing and degradation in the cytoplasm and nucleus. 44 The exosome complex contains a 9-subunit noncatalytic exosome core associated with the hydrolytic subunits RRP6 and RRP44. 45 The exosome complex has low intrinsic exonuclease activity and requires association with activating cofactors for targeting RNA substrates. 46, 47 Here, we showed that CELF1 bound to Cx43 mRNA and interacted with RRP6 functioning as its cofactor to regulate Cx43 mRNA degradation. Consistent with the temporal and spatial expression patterns of CELF1, RRP6 expression in cardiomyocytes was high in the embryonic mouse heart and downregulated in the adult heart but was reexpressed in diseased cardiac tissue. We report for the first time that RRP6 is a CELF1-interacting protein and the CELF1-RRP6 complex regulating Cx43 mRNA degradation provides a mechanism for the pathogenesis of DCM such as DM1 and MI.
During post-MI phenotype progression, Celf1 FF /MCM hearts exhibited reduced fibrosis, near-normal LVID in end systole, and improved contractility when compared with control hearts. This Celf1 depletion-associated protection effect was likely or partially because of preservation of CELF1-regulated target mRNAs such as Tnnt2, Tbx5, and Cx43, via promoting beneficial remodeling process early after MI. For example, the mRNA level of Cx43 was preserved in Celf1 FF / MCM hearts as early as 1 week post-MI. Reduced Cx43 level has been found associated with increased formation of collagen deposition in response to transverse aortic banding. 48 Thus, the protective effect of reduced fibrosis in Celf1 FF / MCM hearts may be contributed by preservation of Cx43 level. Moreover, the combination of the preserved functions contributed by CELF1-regulated target genes resulted in improved cardiac contractility. Depletion of Celf1 in infarcted hearts preserved a fraction of CELF1-regulated target mRNAs but not all examined targets. Some Celf1-regulated targets may be also targets regulated by other factors at the transcriptional or post-transcriptional level. Parallel pathways may be activated during the progression of MI; therefore, depletion of Celf1 may partially preserve the mRNA levels of its targets that were coregulated by other factors at a certain stage, but the effect may not be continual.
CELF1 promotes mRNA decay in T cells and muscle cells. 49, 50 In these studies, CELF1-targeted transcripts were identified by using cytoplasmic extracts because degradation of mRNA mainly occurs in the cytoplasm. The mechanism of CELF1-regulated mRNA stability was proposed via the activity of the deadenylase PARN (poly(A)-specific ribonuclease). 51 Elevated nuclear CELF1 expression was first detected in the nuclei of cardiomyocytes expressing expanded CUG RNA, which allowed for investigating the possibility of CELF1 mediating Cx43 mRNA degradation in the nucleus. We found that nuclear localization was required for CELF1 downregulating Cx43 mRNA because disrupted nuclear localization of CELF1 abolished its function. CELF1 interaction with RRP6 was nuclear dependent, so CELF1 may regulate mRNA decay associated with different factors in a tissue-specific manner.
Cx43 expression is tightly controlled via post-translational modification and post-transcriptional regulation. Study of the regulatory mechanism of Cx43 mRNA stability in cardiovascular diseases is limited. The microRNA miR-1 is upregulated in patients with coronary artery disease and animals with infarcted hearts, which results in downregulation of Cx43 expression via inhibition of translation. 9 In contrast, miR-1 is downregulated with misregulation of processing, which increases Cx43 expression in patients with DM1. 52 We found that Cx43 mRNA in cardiomyocytes was unstable, and its mRNA degradation was regulated by CELF1 under pathological conditions including DM1 and in mouse hearts with MI. The discrepancy in Cx43 expression in DM1 hearts between our findings and others is likely because of the heterogenous reduced distribution of Cx43 under pathological conditions, especially in intercalated discs. As well, the detection by disease stage differs, with increased Cx43 expression in adaptation stages but decreased expression in maladaptation stages.
In summary, we showed that CELF1 regulates Cx43 mRNA degradation by interacting with the 3ʹ to 5ʹ exoribonuclease RRP6. Mouse models of DCM showed increased CELF1 expression accompanied with upregulated RRP6 and downregulation of mRNA levels of CELF1-regulated targets. Celf1 knockout in the infarcted hearts preserved Cx43 mRNA level and ameliorated contractility dysfunction demonstrating that increased CELF1 expression contributes to the pathogenesis of Cx43 downregulation during heart failure.
